HealthPartners Institute | MedPath Search

Found 196 clinical trials|View Analysis

Sort by:

Need a comprehensive medical report on "HealthPartners Institute"?

Analyze the latest clinical research and treatment options

Summarize scientific findings from medical journals

Measurement of Insulin Levels in Cerebral Spinal Fluid (CSF) of Healthy Adults After a Single Intranasal Dose

Phase 1

Suspended

Conditions: Healthy

Interventions: Drug: Low dose Regular Insulin
Drug: High dose Regular insulin

First Posted Date: 2023-05-19

Last Posted Date: 2024-09-30

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 12

Registration Number: NCT05866367

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Transmagnetic Stimulation Pilot in Primary Progressive Aphasia

Not Applicable

Completed

Conditions: Primary Progressive Aphasia

Interventions: Device: Intermittent theta burst stimulation

First Posted Date: 2023-05-16

Last Posted Date: 2024-05-06

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 3

Registration Number: NCT05860647

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

Comparison of ICG Microangiography and Conventional Angiography in Severe Frostbite

Recruiting

Conditions: Frostbite

First Posted Date: 2023-03-21

Last Posted Date: 2025-03-25

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 20

Registration Number: NCT05777590

Locations: 🇺🇸
Regions Hospital, Saint Paul, Minnesota, United States

Geriatric Lateral Compression 1 Pelvic Fractures

Not Applicable

Recruiting

Conditions: Lateral Compression 1 Pelvic Fracture

Interventions: Procedure: Percutaneous screw fixation
Other: Pain management
Other: Physical therapy

First Posted Date: 2023-03-13

Last Posted Date: 2024-08-09

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 100

Registration Number: NCT05765669

Locations: 🇺🇸
Allina, Mercy Hospital, Coon Rapids, Minnesota, United States
🇺🇸
HealthPartners, Regions Hospital, Saint Paul, Minnesota, United States
🇺🇸
Park Nicollet, Methodist Hospital, Saint Louis Park, Minnesota, United States

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Phase 3

Active, not recruiting

Conditions: Atrial Fibrillation

Interventions: Drug: Apixaban
Drug: Milvexian
Drug: Placebo
Drug: Apixaban Placebo

First Posted Date: 2023-03-07

Last Posted Date: 2025-05-23

Lead Sponsor: Janssen Research & Development, LLC

Target Recruit Count: 20296

Registration Number: NCT05757869

Locations: 🇧🇬
UMHAT 'Heart and Brain Center for Excellence', Pleven, Bulgaria
🇧🇬
UMHAT 'Sv. Georgi' EAD, Plovdiv, Bulgaria
🇧🇬
Medical Center- Prolet Ltd, Ruse, Bulgaria

and more 1027 locations

A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment

Not Applicable

Active, not recruiting

Conditions: Dementia
Cognitive Impairment

Interventions: Other: CI-CDS

First Posted Date: 2023-02-10

Last Posted Date: 2025-04-01

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 3001

Registration Number: NCT05723523

Locations: 🇺🇸
HealthPartners, Bloomington, Minnesota, United States
🇺🇸
OCHIN, Inc., Portland, Oregon, United States

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Phase 3

Recruiting

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Gotistobart
Drug: Docetaxel

First Posted Date: 2023-01-04

Last Posted Date: 2025-02-24

Lead Sponsor: OncoC4, Inc.

Target Recruit Count: 600

Registration Number: NCT05671510

Locations: 🇦🇺
Bankstown Hospital - 3305, Bankstown, New South Wales, Australia
🇦🇺
Newcastle Private Hospital - 3302, New Lambton Heights, New South Wales, Australia
🇦🇺
Mater - 3301, Newstead, Queensland, Australia

and more 160 locations

Mindfulness-based Dementia Care Partner Program to Reduce Depressive Symptoms

Not Applicable

Completed

Conditions: Dementia

Interventions: Behavioral: Mindfulness-Based Dementia Caregiving

First Posted Date: 2022-11-15

Last Posted Date: 2025-01-10

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 130

Registration Number: NCT05617300

Locations: 🇺🇸
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

Phase 1

Completed

Conditions: Melanoma (Skin)
Cutaneous Melanoma
Adult Disease
Advanced Solid Tumor
Metastatic Melanoma

Interventions: Drug: ANV419

First Posted Date: 2022-10-13

Last Posted Date: 2025-05-14

Lead Sponsor: Anaveon AG

Target Recruit Count: 29

Registration Number: NCT05578872

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
University of California San Diego, La Jolla, California, United States
🇺🇸
University of California San Francisco, San Francisco, California, United States

and more 22 locations

IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE)

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Device: Continuous Glucose Monitoring (CGM)

First Posted Date: 2022-08-26

Last Posted Date: 2025-03-26

Lead Sponsor: HealthPartners Institute

Target Recruit Count: 178

Registration Number: NCT05516797

Locations: 🇺🇸
Health Partners Institute dba International Diabetes Center, Minneapolis, Minnesota, United States